Meanwhile GSK's lead inhalers include Trelegy Ellipta, projected to bring $3.3bn in 2024 sales, followed by Relvar/Breo Ellipta and Seretide/Advair GlobalData is the patent company of ...
GlobalData on MSN1 个月
Are dry powder inhalers the key to sustainable respiratory care?Meanwhile GSK's lead inhalers include Trelegy Ellipta, projected to bring $3.3bn in 2024 sales, followed by Relvar/Breo Ellipta and Seretide/Advair GlobalData is the patent company of Pharmaceutical ...
How much are you paying for prescription medications? According to an East Tennessee insurance agent, on average, we’re ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈